Stem cell therapy for knee or hip osteoarthritis effectively reduces chronic pain and improves joint mobility, particularly in mild-to-moderate cases. While results vary, patients often experience 30-50% pain reduction. Success depends on treating Grade 2-3 arthritis before bone-on-bone degradation occurs to maximize regenerative potential.
- Treatment eligibility: Most effective for Grade 2 or 3 osteoarthritis with remaining cartilage.
- Clinical outcomes: Provides modest pain relief comparable to advanced corticosteroid treatments for 12 months.
- Procedure logistics: Typically a 1-day outpatient injection performed under local anesthesia or sedation.
- Recovery period: Patients return to light activity quickly with structured physical therapy for 3-6 months.
Bookimed Expert Insight: Data from top Turkish centers shows a shift toward combined protocols for better results. For instance, Turan Turan Health Group offers specialized packages that pair arthroscopic visualization with stem cell delivery. This allows surgeons to deposit cells precisely where cartilage is thinning, rather than relying on a blind injection. Choosing a facility with a GMP-certified lab, such as those led by Professor Erdal Karaöz, ensures higher cell viability and better long-term inflammation management.
Patient Consensus: Many patients report significant relief when treating early-stage arthritis but emphasize that results are not instant. Success often requires pairing the injection with 6 months of dedicated physical therapy and managing expectations regarding a permanent cure.
